Expanding access to diacetylmorphine and hydromorphone for people who use opioids in Canada

Commentary
by
Maghsoudi, Nazli et al

Release Date

2020

Geography

Canada

Language of Resource

English

Full Text Available

No

Open Access / OK to Reproduce

No

Peer Reviewed

Yes

Objective

This commentary explores the current state of policy and practice for diacetylmorphine and hydromorphone as opioid substitution options in Canada, outlines the rationale for rapid expansion of access, and highlights clinical and policy changes that must be undertaken or the death toll will continue to rise.

Findings/Key points

Given the magnitude of opioid related harms among people reliant on the illicit market, there is a need to remove barriers to safe supplies of diacetylmorphine and hydromorphone

Keywords

Policy/Regulatory
Advocacy